{"entity":{"type":"insider","cik":"0001628880","url":"/insider/0001628880","json_url":"/insider/0001628880.json","name":"Pagan Douglas W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":9,"first":"2017-02-08","last":"2019-02-07","span_basis":"filed_date"},"name_variants":[{"name":"Pagan Douglas W.","source":"filing","n_filings":9,"first_seen":"2017-02-08","last_seen":"2019-02-07"}],"transactions":[{"id":8611845,"accession":"0000904454-19-000180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-19-000180","line_url":"/filing/0000904454-19-000180#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001628880","owner_name":"Pagan Douglas W.","owner_display_name":"Pagan Douglas W.","owner_url":"/insider/0001628880","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2495.0,"shares_display":"2,495","price_per_share":6.77,"price_display":"6.77","price_state":"stated","total_value":16891.15,"total_display":"16,891.15","total_whole":"16,891","shares_owned_after":134057.0,"shares_owned_after_display":"134,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-07","scope":"insider"},{"id":6514588,"accession":"0000904454-18-000787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000787","line_url":"/filing/0000904454-18-000787#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001628880","owner_name":"Pagan Douglas W.","owner_display_name":"Pagan Douglas W.","owner_url":"/insider/0001628880","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2918.0,"shares_display":"2,918","price_per_share":6.76,"price_display":"6.76","price_state":"stated","total_value":19725.68,"total_display":"19,725.68","total_whole":"19,726","shares_owned_after":120302.0,"shares_owned_after_display":"120,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-14","scope":"insider"},{"id":6774111,"accession":"0000904454-18-000667","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-18-000667","line_url":"/filing/0000904454-18-000667#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001628880","owner_name":"Pagan Douglas W.","owner_display_name":"Pagan Douglas W.","owner_url":"/insider/0001628880","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2784.0,"shares_display":"2,784","price_per_share":8.96,"price_display":"8.96","price_state":"stated","total_value":24944.64,"total_display":"24,944.64","total_whole":"24,945","shares_owned_after":123220.0,"shares_owned_after_display":"123,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-16","scope":"insider"},{"id":6217818,"accession":"0000904454-18-000644","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-18-000644","line_url":"/filing/0000904454-18-000644#line-3","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001628880","owner_name":"Pagan Douglas W.","owner_display_name":"Pagan Douglas W.","owner_url":"/insider/0001628880","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7579.0,"shares_display":"7,579","price_per_share":9.82,"price_display":"9.82","price_state":"stated","total_value":74425.78,"total_display":"74,425.78","total_whole":"74,426","shares_owned_after":119504.0,"shares_owned_after_display":"119,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-03","filed_date":"2018-10-04","scope":"insider"},{"id":6678995,"accession":"0000904454-18-000289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000289","line_url":"/filing/0000904454-18-000289#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001628880","owner_name":"Pagan Douglas W.","owner_display_name":"Pagan Douglas W.","owner_url":"/insider/0001628880","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5237.0,"shares_display":"5,237","price_per_share":12.7,"price_display":"12.70","price_state":"stated","total_value":66509.9,"total_display":"66,509.90","total_whole":"66,510","shares_owned_after":77083.0,"shares_owned_after_display":"77,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-09","filed_date":"2018-04-10","scope":"insider"},{"id":6619563,"accession":"0000904454-18-000131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000131","line_url":"/filing/0000904454-18-000131#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001628880","owner_name":"Pagan Douglas W.","owner_display_name":"Pagan Douglas W.","owner_url":"/insider/0001628880","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16291.0,"shares_display":"16,291","price_per_share":14.22,"price_display":"14.22","price_state":"stated","total_value":231658.02,"total_display":"231,658.02","total_whole":"231,658","shares_owned_after":39570.0,"shares_owned_after_display":"39,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":4104971,"accession":"0000904454-17-000497","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-17-000497","line_url":"/filing/0000904454-17-000497#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001628880","owner_name":"Pagan Douglas W.","owner_display_name":"Pagan Douglas W.","owner_url":"/insider/0001628880","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4139.0,"shares_display":"4,139","price_per_share":23.5788,"price_display":"23.58","price_state":"stated","total_value":97592.6532,"total_display":"97,592.65","total_whole":"97,593","shares_owned_after":55861.0,"shares_owned_after_display":"55,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-06","scope":"insider"},{"id":4104961,"accession":"0000904454-17-000450","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-17-000450","line_url":"/filing/0000904454-17-000450#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001628880","owner_name":"Pagan Douglas W.","owner_display_name":"Pagan Douglas W.","owner_url":"/insider/0001628880","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4595.0,"shares_display":"4,595","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":114875.0,"total_display":"114,875.00","total_whole":"114,875","shares_owned_after":51000.0,"shares_owned_after_display":"51,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-21","scope":"insider"},{"id":4692451,"accession":"0000904454-17-000137","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000904454-17-000137","line_url":"/filing/0000904454-17-000137","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Paratek Pharmaceuticals, Inc.","issuer_ticker":"PRTK","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001628880","owner_name":"Pagan Douglas W.","owner_display_name":"Pagan Douglas W.","owner_url":"/insider/0001628880","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3405.0,"shares_display":"3,405","price_per_share":15.09363436123348,"price_display":"15.09","price_state":"stated","total_value":51393.825,"total_display":"51,393.82","total_whole":"51,394","shares_owned_after":56823.0,"shares_owned_after_display":"56,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-08","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178711","name":"Paratek Pharmaceuticals, Inc.","url":"/issuer/0001178711","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2017-02-08","last_seen":"2019-02-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001628880","retrieved_at":"2026-08-25T05:01:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}